ENTITY
Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals (PAR AU)

20
Analysis
Health CareAustralia
Paradigm Biopharmaceuticals Limited operates as a biopharmaceutical company. The Company develops PPS drug to treat respiratory diseases such as allergic asthma, allergic rhinitis, and chronic obstructive pulmonary. Paradigm Biopharmaceuticals offers its services in Australia.
more
Publication Icon
No publications yet
There aren’t any syndicated reports right now
Back to "All"
x